SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Perilongo, G.
Right arrow Articles by Murgia, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perilongo, G.
Right arrow Articles by Murgia, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Spontaneous Partial Regression of Low-Grade Glioma in Children With Neurofibromatosis-1: A Real Possibility

Giorgio Perilongo, MD

Hematology-Oncology Division, Padua University Hospital, Pediatric Neuro-Oncology Program, Padua, Italy

Paola Moras, MD

Neurology Division, Padua University Hospital, Pedicatric Neuro-Oncology Program, Padua, Italy

Carla Carollo, MD

Department of Pediatrics, the Division of Neuroradiology, Padua University Hospital, Pediatric Neuro-Oncology Program, Padua, Italy

Antonio Battistella, MD

Neurology Division, Padua University Hospital, Pedicatric Neuro-Oncology Program, Padua, Italy

Maurizio Clementi, MD

Divison of Medical Genetics Padua University Hospital, Pediatric Neuro-Oncology Program, Padua, Italy

AnnaMaria Laverda, MD

Neurology Division, Padua University Hospital, Pedicatric Neuro-Oncology Program, Padua, Italy

Alessandra Murgia, PhD, MD

Molecular Biology Unit, Padua University Hospital, Pedicatric Neuro-Oncology Program, Padua, Italy

At the age of 41 and 31 months, respectively, a boy and a girl affected by neurofibromatosis-1 were diagnosed with a visual pathway glioma during surveillance contrast-enhanced head magnetic resonance imaging (MRI). In the first child, the initial MRI showed that the entire optic chiasm, the intracranial tract of the left optic nerve, and hypothalamus were grossly enlarged and enhanced in the post-gadolinium T1-weighted images. Ten months later, the hypothalamic component of the lesion had regressed markedly and there were no more areas of contrast enhancement. In the second child, the initial MRI showed that the optic chiasm, the right optic tract, and geniculate body were enlarged and enhanced after gadolinium injection. At 6-month follow-up, the MRI showed that the right optic tract and the anterior aspect of the optic chiasm decreased in size and the contrast enhancement of the entire lesion was reduced dramatically. These findings, as indicated by other similar reports, confirm that spontaneous regression of visual pathway glioma is a rare but real possibility in children with neurofibromatosis-1. Therefore, clinicians need to be aware of visual pathway glioma's erratic behavior in children with neurofibromatosis-1 with special attention given to the importance of a very conservative attitude toward any type of treatment for such patients. (J Child Neurol 1999;14:352-356).

Journal of Child Neurology, Vol. 14, No. 6, 352-356 (1999)
DOI: 10.1177/088307389901400602


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Br J OphthalmolHome page
C F Parsa and S Givrad
Pilocytic astrocytomas as hamartomas: implications for treatment
Br J Ophthalmol, January 1, 2008; 92(1): 3 - 6.
[Full Text] [PDF]


Home page
Br J OphthalmolHome page
C F Parsa and S Givrad
Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas
Br J Ophthalmol, January 1, 2008; 92(1): 40 - 46.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. H. Gutmann, S. A. Rasmussen, P. Wolkenstein, M. M. MacCollin, A. Guha, P. D. Inskip, K. N. North, M. Poyhonen, P. H. Birch, and J. M. Friedman
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1)
Neurology, September 10, 2002; 59(5): 759 - 761.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
H. Young, S. Hyman, and K. North
Review Article : Neurofibromatosis 1: Clinical Review and Exceptions to the Rules
J Child Neurol, August 1, 2002; 17(8): 613 - 621.
[Abstract] [PDF]


Home page
J Child NeurolHome page
T. Rosser and R. J. Packer
Review Article : Intracranial Neoplasms in Children With Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 630 - 637.
[Abstract] [PDF]


Home page
Arch OphthalmolHome page
C. F. Parsa, C. S. Hoyt, R. L. Lesser, J. M. Weinstein, C. M. Strother, R. Muci-Mendoza, M. Ramella, R. S. Manor, W. A. Fletcher, M. X. Repka, et al.
Spontaneous Regression of Optic Gliomas: Thirteen Cases Documented by Serial Neuroimaging
Arch Ophthalmol, April 1, 2001; 119(4): 516 - 529.
[Abstract] [Full Text] [PDF]



Advertisement